Business Context and Reporting Period
Company: Disc Medicine, Inc. (Nasdaq: IRON)
Filing Type: Form 8-K (Current Report)
Date of Report: December 7, 2025
Event: The Company held a conference call and webcast to review data presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, along with operational plans.
Key Financial Metrics
This filing is a Current Report on Form 8-K regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes or operational updates are detailed within the text of this specific filing. The report serves solely to announce the occurrence of the conference call and to incorporate the presentation materials by reference.
Guidance, Outlook, and Risks
- Management Commentary: The Company reviewed clinical data from the ASH Annual Meeting and discussed operational plans during the conference call.
- Forward-Looking Statements: The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached as Exhibit 99.1.
- Risks: No specific risks or contingencies are enumerated in the body of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (the attached presentation) for specific clinical data results from the ASH Annual Meeting.
- Verify the details of the Company's operational plans discussed during the December 7, 2025, webcast.
- Consult the most recent 10-Q or 10-K filing for current financial metrics, as this 8-K does not contain financial data.